Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer and President of R&D. Dr. Basson brings more than 25 ...

ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...

This article is authored by Dr. GSK Velu, healthtech entrepreneur and CMD, Maxivision, Neuberg and Trivitron.

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa™ Lymphoma test ...

In 2025, Baylor Genetics was named an official genetic testing partner of the Child Neurology Society.

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Genomic medicine has the potential to impact all areas of medicine and change clinical practice. In contrast to the trial-and-error of today’s practice, genomic ...

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, has appointed four new hires to its leadership team. 1. Laurie Huard, now the company’s COO, ...

CHENNAI: The University of Madras has begun offering a clinical genomics week-long elective certificate course to final-year ...